4.51
price down icon4.75%   -0.225
after-market Handel nachbörslich: 4.50 -0.010 -0.22%
loading
Schlusskurs vom Vortag:
$4.735
Offen:
$4.69
24-Stunden-Volumen:
1.26M
Relative Volume:
0.96
Marktkapitalisierung:
$421.24M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-10.02
EPS:
-0.45
Netto-Cashflow:
$-24.91M
1W Leistung:
-1.31%
1M Leistung:
-8.89%
6M Leistung:
+41.82%
1J Leistung:
+132.47%
1-Tages-Spanne:
Value
$4.44
$4.69
1-Wochen-Bereich:
Value
$4.36
$4.88
52-Wochen-Spanne:
Value
$1.84
$6.23

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Firmenname
Aquestive Therapeutics Inc
Name
Telefon
908-941-1900
Name
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Mitarbeiter
135
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-18
Name
Neueste SEC-Einreichungen
Name
AQST's Discussions on Twitter

Vergleichen Sie AQST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
AQST 4.51 421.24M 58.36M -25.72M -24.91M -0.45
ZTS 176.71 79.55B 9.15B 2.43B 2.31B 4.92
HLN 9.55 43.18B 14.26B 1.55B 0 0.3327
TAK 13.33 42.26B 30.27B 1.93B 3.45B 0.444
TEVA 17.08 19.35B 16.77B -959.00M 1.37B -2.00
VTRS 13.25 15.77B 15.24B -646.50M 1.88B 1.53

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2019-04-22 Eingeleitet H.C. Wainwright Buy
2019-01-03 Eingeleitet Lake Street Buy
2018-08-20 Eingeleitet JMP Securities Mkt Outperform
2018-08-20 Eingeleitet RBC Capital Mkts Outperform

Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten

pulisher
Nov 18, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Short Interest Update - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

GSA Capital Partners LLP Acquires 115,223 Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST) - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025? - Insider Monkey

Nov 16, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Aquestive Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Chartwell Investment Partners LLC Buys New Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - MarketBeat

Nov 14, 2024
pulisher
Nov 12, 2024

Aquestive Therapeutics, Inc. Announces Board and Committee Changes - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Aquestive Therapeutics to Present at Jefferies and Piper Sandler Healthcare Conferences | AQST Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 09, 2024

Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics - Seeking Alpha

Nov 09, 2024
pulisher
Nov 09, 2024

(AQST) On The My Stocks Page - Stock Traders Daily

Nov 09, 2024
pulisher
Nov 08, 2024

HC Wainwright Issues Pessimistic Estimate for AQST Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Leerink Partnrs Issues Optimistic Forecast for AQST Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Aquestive Therapeutics announces board changes - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Aquestive Therapeutics announces board changes By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 06, 2024

Aquestive Therapeutics Advances Drug Candidates Amid Challenges - TipRanks

Nov 06, 2024
pulisher
Nov 06, 2024

Lake Street lifts Aquestive stock target, keeps buy on NDA submission - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

Aquestive Therapeutics (NASDAQ:AQST) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

Aquestive Therapeutics: Progress in Drug Innovation - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Aquestive: Rare Opportunity With Dual Platform Strategy (NASDAQ:AQST) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

Aquestive Therapeutics (NASDAQ:AQST) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Aquestive Therapeutics: Q3 Earnings Snapshot - mySA

Nov 05, 2024
pulisher
Nov 05, 2024

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN

Nov 05, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics reports Q3 EPS (13c), consensus (13c) - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

AQSTAquestive Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Optimistic Financial and Strategic Outlook - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 04, 2024
pulisher
Nov 01, 2024

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need T - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $8.83 Consensus Target Price from Brokerages - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

Learn to Evaluate (AQST) using the Charts - Stock Traders Daily

Oct 29, 2024
pulisher
Oct 28, 2024

Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $13.00 - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

Aquestive Therapeutics (AQST) Set to Announce Quarterly Earnings on Monday - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Leerink raises Aquestive Therapeutics stock PT on 'top-line' study results - Investing.com Canada

Oct 26, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics to Present Subsequent Analysis of - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Leerink Partners Raises Aquestive Therapeutics (NASDAQ:AQST) Price Target to $13.00 - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics (NASDAQ:AQST) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$51m last week but individual investors profited the most - Simply Wall St

Oct 25, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics' SWOT analysis: stock poised for growth as Anaphylm nears FDA submission - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Pushes Retail Sentiment Into ‘Extremely Bullish’ Zone On OAS Drug Trial Success - Barchart

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics' SWOT analysis: stock poised for growth as Anaphylm nears FDA submission By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Inc (AQST) Has Recovered 74.67% From Its Low: Is This The Beginning Of A Trend? - Stocks Register

Oct 24, 2024
pulisher
Oct 24, 2024

Aquestive Therapeutics Announces Positive Topline Results - GlobeNewswire

Oct 24, 2024
pulisher
Oct 22, 2024

Aquestive Therapeutics a new overweight at Piper on oral film products - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Aquestive Therapeutics to Report Third Quarter 2024 - GlobeNewswire

Oct 21, 2024
pulisher
Oct 16, 2024

Aquestive Therapeutics updates bylaws, shortens nomination look-back By Investing.com - Investing.com South Africa

Oct 16, 2024

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aquestive Therapeutics Inc-Aktie (AQST) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Schobel Alexander Mark
Chief Innovation/Tech Officer
Mar 08 '24
Sale
5.19
25,000
129,685
1,040,371
$87.32
price up icon 1.01%
$13.40
price down icon 0.30%
$85.45
price down icon 0.22%
$59.66
price up icon 1.12%
$125.00
price up icon 1.39%
$13.25
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):